Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 302

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Antibiotic resistance management

Open access
Read, A. F., Woods, R. J. · 2014 · Evolution, Medicine, and Public Health

Abstract

Antibiotic resistance is ‘bacteria changing in ways that reduce or eliminate the effectiveness of antibiotics’ [1]. These changes are due to bacterial evolution, and threaten the single greatest therapeutic advance in the history of medicine. Antibiotic resistance genes arose long ago in response to naturally occurring antibiotics. Modern medicine has driven further evolution of some of these genes. Resistance can also arise spontaneously by mutation. In bacteria, genes can be inherited or they can be acquired from non-relatives on mobile genetic elements like plasmids. This horizontal gene transfer (HGT) can occur between very different bacteria. Antibiotic use drives the evolution of resistance [2]. Resistant bacteria spread by natural selection when antibiotics fail to halt their reproduction while removing their drug-sensitive competitors. Antibiotic resistance management is an attempt to slow the spread of resistance by the judicious use of antibiotics, an important aim of antibiotic stewardship programs. One way the evolution of antibiotic resistance can be slowed is by minimizing the strength of natural selection for resistance genes. This means reducing antibiotic use. Don’t treat asymptomatic infections. Use antibiotics only where they can work. 70% of acute bronchitis cases are treated with antibiotics to no effect [3]. When treatment is necessary, use as little as possible. Decrease the need for antibiotic treatment with vaccines, hygiene, and isolation of infected patients. Prevent non-medical uses like growth promotion in farm animals. Reducing antibiotic use also limits selection for resistance in harmless bacteria that can donate genes to pathogens by HGT, as does targeting pathogens with narrow spectrum antibiotics. Another way to slow resistance evolution is to prevent pathogens acquiring resistance genes in the first place. In some cases, this can be done with high doses (dead bugs can’t evolve) or combination therapy (acquiring resistance to several drugs at once is unlikely). Bottom line: antibiotics should be used only when necessary and then, appropriately. What constitutes appropriate use of antibiotics can be controversial. For instance, dead bugs can’t acquire resistance, so aggressively killing pathogenic bacteria with antibiotics can retard resistance evolution. But aggressive treatment also maximizes the evolutionary advantage of already resistant pathogens or of non-target bacteria that can be a source of resistance genes. Consequently, treatments designed to minimize the rate of resistance acquisition might not be best when resistance is already present [4]. Other major research questions: (i) when do drug cocktails select for multidrug resistance faster than sequential monotherapies?, (ii) does repeated antibiotic use generate a microbiomic reservoir of resistance genes for future pathogens?, (iii) what properties of particular drugs make them more evolution-proof than others?, and (iv) is inappropriate antibiotic use the main evolutionary force undermining drug efficacy—or is it medically appropriate use?

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/emph/eou024

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Read, A. F., & Woods, R. J.
Venue
Evolution, Medicine, and Public Health
Published
2014-10-28
Volume
2014
Issue
1
Pages
147-147
ISSN
2050-6201 (ISSN-L)
OpenAlex
W2111604015
Cited by
302
References
3
FWCI
4.95
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.